Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.

PMID:
17018786
2.

Long term hormone therapy for perimenopausal and postmenopausal women.

Farquhar CM, Marjoribanks J, Lethaby A, Lamberts Q, Suckling JA; Cochrane HT Study Group.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004143. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD004143.

PMID:
16034922
3.

Menopausal hormones and risk of ovarian cancer.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A.

Am J Obstet Gynecol. 2005 Jul;193(1):76-82.

PMID:
16021062
4.
5.

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.

Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J.

Arch Intern Med. 2004 Nov 8;164(20):2253-9.

PMID:
15534163
6.

Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California.

Mills PK, Riordan DG, Cress RD.

Gynecol Oncol. 2004 Oct;95(1):215-25.

PMID:
15385135
7.

Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.

Riman T, Nilsson S, Persson IR.

Acta Obstet Gynecol Scand. 2004 Sep;83(9):783-95. Review.

PMID:
15315588
8.

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

Bakken K, Alsaker E, Eggen AE, Lund E.

Int J Cancer. 2004 Oct 20;112(1):130-4.

9.

Estrogens and epithelial ovarian cancer.

Cunat S, Hoffmann P, Pujol P.

Gynecol Oncol. 2004 Jul;94(1):25-32. Review.

PMID:
15262115
10.

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study.

Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH.

Fertil Steril. 2004 Jul;82(1):186-95. Erratum in: Fertil Steril. 2004 Aug;82(2):516.

PMID:
15237010
11.

Estrogen replacement therapy and ovarian cancer.

Folsom AR, Anderson JP, Ross JA.

Epidemiology. 2004 Jan;15(1):100-4.

PMID:
14712153
12.

Estrogen, progesterone and epithelial ovarian cancer.

Ho SM.

Reprod Biol Endocrinol. 2003 Oct 7;1:73. Review.

13.

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.

Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM; Women's Health Initiative Investigators.

JAMA. 2003 Oct 1;290(13):1739-48.

PMID:
14519708
14.

Breast cancer and hormone-replacement therapy in the Million Women Study.

Beral V; Million Women Study Collaborators.

Lancet. 2003 Aug 9;362(9382):419-27. Erratum in: Lancet. 2003 Oct 4;362(9390):1160.

PMID:
12927427
15.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
16.

Obesity, weight gain, and ovarian cancer.

Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE.

Obstet Gynecol. 2002 Aug;100(2):288-96.

PMID:
12151152
17.

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

Sit AS, Modugno F, Weissfeld JL, Berga SL, Ness RB.

Gynecol Oncol. 2002 Aug;86(2):118-23.

PMID:
12144815
18.

Menopausal hormone replacement therapy and risk of ovarian cancer.

Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C.

JAMA. 2002 Jul 17;288(3):334-41. Erratum in: JAMA 2002 Nov 27;288(20):2544.

PMID:
12117398
19.

Dietary fat intake and ovarian cancer in a cohort of US women.

Bertone ER, Rosner BA, Hunter DJ, Stampfer MJ, Speizer FE, Colditz GA, Willett WC, Hankinson SE.

Am J Epidemiol. 2002 Jul 1;156(1):22-31.

PMID:
12076885
20.

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR.

J Natl Cancer Inst. 2002 Apr 3;94(7):497-504.

PMID:
11929950

Supplemental Content

Support Center